Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Moderna, Inc.
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:

- Collaboration revenue (79.8%);

- Grant revenue (20.2%).

At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and three in phase I.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Transformative Medicines135.07100%60.21100% -55.42%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States135.07100%60.21100% -55.42%
Managers and Directors
NameAgeSinceTitle
Stéphane Bancel472011Chief Executive Officer & Director
Stephen Hoge442015President
David Meline622020Chief Financial Officer
Noubar Afeyan572012Chairman
Juan Andres552017Chief Technical Operations & Quality Officer
Tal Zaks552015Chief Medical Officer
Paul Sagan612018Independent Non-Executive Director
Robert Langer722010Independent Non-Executive Director
Stephen A. Berenson592017Independent Non-Executive Director
Francois Nader632019Independent Non-Executive Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 399,769,582 356,195,060 89.1% 0 0.0% 89.1%
Shareholders
NameEquities%
Flagship Pioneering 24,333,423 6.15%
Baillie Gifford & Co. 24,312,271 6.14%
Stéphane Bancel 23,183,780 5.86%
The Vanguard Group, Inc. 22,687,508 5.73%
Robert Langer 11,509,357 2.91%
Fidelity Management & Research Co. LLC 7,940,013 2.01%
BlackRock Fund Advisors 7,391,851 1.87%
SSgA Funds Management, Inc. 6,024,687 1.52%
Thélème Partners LLP 5,343,698 1.35%
Geode Capital Management LLC 3,571,240 0.90%
Markets and indexes
-
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  MRNA.O
- Datastream Code :  
Company contact information
Moderna, Inc.
200 Square Technology
MA 02139 Cambridge, Massachusetts


Phone : +1 617 714 6500
Fax : +1 617 583 1998
web site : https://www.modernatx.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Moderna, Inc.
Sector Other Biotechnology & Medical Research